DD Dittrich KAV - Vienna OMI

13.02.2012
Prim. Univ. Prof. Dr. Christian Dittrich
Vienna Hospital Association
Sozialmedizinisches Zentrum Süd
Kaiser-Franz-Josef-Spital
3rd Medical Department -
Centre for Oncology and Haematology
1100 Wien, Kundratstraße 3
Tel.: (+43 1) 60191 2301
Fax: (+43 1) 60191 2329
christian.dittrich@wienkav.at
http://www.wienkav.at/kfj
Department Description
3rd Department of Medicine - Center for Oncology and Hematology
Head: Prim.Univ.-Prof.Dr. Christian Dittrich
The scope of service includes all steps from the investigation of tumors (in respect of their
dignity and characterization) to forecasting and consulting. Therapy and its follow-up are our
central activities. The Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR
Vienna) - Cluster Translational Oncology, led by Professor Dittrich, is a study center and the
basis for the permanent new offer of treatment, experimental drugs and therapies in clinical
trials.
Infrastructure
The department has two inpatient-wards, a day hospital and an ambulance.
The so-called interdisciplinary oncology platform is an interdisciplinary institution and lived
expression of the overall attitude of the hospital and the third Medical Department - Center
for Oncology and Hematology in particular. A psycho-oncology service complements the
care offered by the Department.
This hemato-oncology laboratory allows rapid and direct control of a variety of antitumor
therapies, particularly those on the type of cytostatic-cytotoxic chemotherapy, in which the
hematotoxicity is the most common limiting toxicity.

13.02.2012
Disease spectrum
The spectrum of patients is very broad and reflects long distances the natural distribution
pattern of malignancies. In certain areas there is an above-average frequency of patients
who are assigned from the regional and trans-regional area, because of specific in-house
expertises and treatment services.
Disproportionately represented are tumors of the gastrointestinal tract, breast cancers and all
other gynecological tumors, tumors of the urogenital tract with special emphasis on testicular
tumors, tumors of the head and neck region, brain, and not least malignant lymphomas.
Therapeutic approaches
The goals of therapy extend from the cure to prevention.
The spectrum of medical tumor therapy involves the classical cytostatic, cytotoxic
chemotherapy, the complete range of (anti-) hormonal measures, immunotherapy such as
with cytokines, antibodies and vaccines, as well as approaches such as the induction of
differentiation and the gift of target structure-oriented ( "targeted") therapies, eg with
signaltransductionmodulators. Active antitumor drugs are often complemented by supportive
therapies such as analgesics, antiemetics, hematopoietic growth factors or
Schleimhautprotektiva.